Andrew Bindman, MD, is Executive Vice President and Chief Medical Officer for Kaiser Permanente. He is responsible for driving superior quality and equitable health outcomes through the integration of quality innovation, care delivery, and research in collaboration with the Permanente Medical Groups. He is also Kaiser Permanente’s executive sponsor for the Kaiser Permanente Bernard J. Tyson School of Medicine.
Dr. Bindman previously spent more than 30 years at the University of California, San Francisco where he practiced and taught clinical medicine while conducting research in health access and outcomes that resulted in more than 180 published scientific articles. A noted policy expert, he has held advisory and leadership roles for the U.S. House Energy and Commerce Committee, the U.S. Department of Health and Human Services, the Healthy California for All Commission, and the Agency for Healthcare Research and Quality.
Dr. Bindman is a graduate of Harvard College and the Mount Sinai School of Medicine. A board-certified general internist, he completed his residency in internal medicine at UCSF and was a Robert Wood Johnson Foundation Clinical Scholar at Stanford University. He was elected to the National Academy of Medicine in 2015, where he currently serves on the board for health care services and chairs the workshops on diagnostic excellence. In 2021, he was elected to the Association of American Physicians in recognition for his notable contributions to advancing scientific and practical medicine.